Drug Combination on Exercise Performance at High Altitude

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Acute Mountain Sickness

In brief

This study is being conducted to determine the effectiveness of using two FDA approved medications in concert to reduce the likelihood of sickness due to low oxygen levels and to reduce the decrement in physical performance at higher elevations. The investigators hypothesize that this drug combination will reduce the symptoms of acute mountain sickness and improve exercise performance at high altitude compared to placebo.

Key facts

Study ID

NCT01902758

Run by

University of Montana

People needed

28

Starts

2013-08-01

Expected to finish

2013-08-01

Last updated by the study team

2016-02-26

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• healthy males

You may not qualify if…

• VO2max below 45ml/kg/min
• currently taking any medication

Where it is running

• Montana Center for Work Physiology and Exercise Metabolism — Missoula, Montana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.